Young M M
Pharmatherapeutica. 1982;3(2):86-92.
Stable cream formulations containing 0.1% or 0.2% dithranol in a 17% urea base have been developed. A double-blind comparative trial in 20 out-patients showed that over a 6-week treatment period the 0.2% dithranol and urea cream was significantly more effective (p less than 0.01) than the 0.1% dithranol and urea cream in clearing chronic plaque psoriasis. The 0.2% dithranol/urea cream was accompanied by a higher incidence of minor, irritant side-effects, but was still well accepted by patients for use at home. The availability of differing strengths of dithranol and urea cream enables practitioners to tailor dithranol treatment in accordance with the individual patient's clinical response.
已研发出在17%尿素基质中含有0.1%或0.2%地蒽酚的稳定乳膏制剂。一项针对20名门诊患者的双盲对照试验表明,在为期6周的治疗期内,0.2%地蒽酚尿素乳膏在清除慢性斑块状银屑病方面比0.1%地蒽酚尿素乳膏显著更有效(p<0.01)。0.2%地蒽酚/尿素乳膏伴随的轻微刺激性副作用发生率更高,但仍被患者很好地接受用于居家使用。不同浓度的地蒽酚和尿素乳膏可供使用,使从业者能够根据个体患者的临床反应调整地蒽酚治疗方案。